The observed frequencies of the mutations in this series of patients are similar to the frequencies of the 737 CRC cases, including the rectosigmoid cancer cases, for whom K-ras mutation status was determined (Brink et al, 2003). The gene discussed is KRAS; the disease is rectosigmoid carcinoma.